|
|
 |
 |
| |
 Printable version |
Levothyrox®, Avandia®, Mediator®: Bankruptcy Agencies |
Médecine. Volume 6, Number 10, 440-2, Décembre 2010, Editorial
|
 Article gratuit
|
Author(s) : Michel Gerson |
Summary : For those interested in both pharmacovigilance and endocrinology, the year 2010 has been “auspicious”: Levothyrox®, Avandia®, Mediator®... One can conclude from weaknesses in the drug policy in France: political bounded generics, drug-winded and opaque decisions disconnected from the benefit/risk balance, lack of information policy on medication and overall reflection on its proper use...
|
Keywords : government agency, drugs, generic, risk
|
|
